102 related articles for article (PubMed ID: 27473135)
41. Bioidentical menopausal hormone therapy: registered hormones (non-oral estradiol ± progesterone) are optimal.
L'Hermite M
Climacteric; 2017 Aug; 20(4):331-338. PubMed ID: 28301216
[TBL] [Abstract][Full Text] [Related]
42. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
43. Effects of hormone therapy on brain structure: A randomized controlled trial.
Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Gunter JL; Gleason CE; Wharton W; Dowling NM; Vemuri P; Senjem ML; Shuster LT; Bailey KR; Rocca WA; Jack CR; Asthana S; Miller VM
Neurology; 2016 Aug; 87(9):887-96. PubMed ID: 27473135
[TBL] [Abstract][Full Text] [Related]
44. Early Postmenopausal Transdermal 17β-Estradiol Therapy and Amyloid-β Deposition.
Kantarci K; Lowe VJ; Lesnick TG; Tosakulwong N; Bailey KR; Fields JA; Shuster LT; Zuk SM; Senjem ML; Mielke MM; Gleason C; Jack CR; Rocca WA; Miller VM
J Alzheimers Dis; 2016 May; 53(2):547-56. PubMed ID: 27163830
[TBL] [Abstract][Full Text] [Related]
45. Brain structure and cognition 3 years after the end of an early menopausal hormone therapy trial.
Kantarci K; Tosakulwong N; Lesnick TG; Zuk SM; Lowe VJ; Fields JA; Gunter JL; Senjem ML; Settell ML; Gleason CE; Shuster LT; Bailey KR; Dowling NM; Asthana S; Jack CR; Rocca WA; Miller VM
Neurology; 2018 Apr; 90(16):e1404-e1412. PubMed ID: 29661902
[TBL] [Abstract][Full Text] [Related]
46. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS).
Taylor HS; Tal A; Pal L; Li F; Black DM; Brinton EA; Budoff MJ; Cedars MI; Du W; Hodis HN; Lobo RA; Manson JE; Merriam GR; Miller VM; Naftolin F; Neal-Perry G; Santoro NF; Harman SM
JAMA Intern Med; 2017 Oct; 177(10):1471-1479. PubMed ID: 28846767
[TBL] [Abstract][Full Text] [Related]
47. Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).
Cintron D; Lahr BD; Bailey KR; Santoro N; Lloyd R; Manson JE; Neal-Perry G; Pal L; Taylor HS; Wharton W; Naftolin F; Harman SM; Miller VM
Menopause; 2018 Feb; 25(2):145-153. PubMed ID: 28832429
[TBL] [Abstract][Full Text] [Related]
48. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study.
Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S
PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291
[TBL] [Abstract][Full Text] [Related]
49. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
Harman SM; Black DM; Naftolin F; Brinton EA; Budoff MJ; Cedars MI; Hopkins PN; Lobo RA; Manson JE; Merriam GR; Miller VM; Neal-Perry G; Santoro N; Taylor HS; Vittinghoff E; Yan M; Hodis HN
Ann Intern Med; 2014 Aug; 161(4):249-60. PubMed ID: 25069991
[TBL] [Abstract][Full Text] [Related]
50. Oophorectomy, estrogen, and dementia: a 2014 update.
Rocca WA; Grossardt BR; Shuster LT
Mol Cell Endocrinol; 2014 May; 389(1-2):7-12. PubMed ID: 24508665
[TBL] [Abstract][Full Text] [Related]
51. Change in brain and lesion volumes after CEE therapies: the WHIMS-MRI studies.
Coker LH; Espeland MA; Hogan PE; Resnick SM; Bryan RN; Robinson JG; Goveas JS; Davatzikos C; Kuller LH; Williamson JD; Bushnell CD; Shumaker SA;
Neurology; 2014 Feb; 82(5):427-34. PubMed ID: 24384646
[TBL] [Abstract][Full Text] [Related]
52. Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance.
Dowling NM; Gleason CE; Manson JE; Hodis HN; Miller VM; Brinton EA; Neal-Perry G; Santoro MN; Cedars M; Lobo R; Merriam GR; Wharton W; Naftolin F; Taylor H; Harman SM; Asthana S
PLoS One; 2013; 8(7):e68741. PubMed ID: 23874743
[TBL] [Abstract][Full Text] [Related]
53. Long-term effects on cognitive function of postmenopausal hormone therapy prescribed to women aged 50 to 55 years.
Espeland MA; Shumaker SA; Leng I; Manson JE; Brown CM; LeBlanc ES; Vaughan L; Robinson J; Rapp SR; Goveas JS; Wactawski-Wende J; Stefanick ML; Li W; Resnick SM;
JAMA Intern Med; 2013 Aug; 173(15):1429-36. PubMed ID: 23797469
[TBL] [Abstract][Full Text] [Related]
54. Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women.
Raz L; Jayachandran M; Tosakulwong N; Lesnick TG; Wille SM; Murphy MC; Senjem ML; Gunter JL; Vemuri P; Jack CR; Miller VM; Kantarci K
Neurology; 2013 Mar; 80(10):911-8. PubMed ID: 23408873
[TBL] [Abstract][Full Text] [Related]
55. Cerebral small-vessel disease and progression of brain atrophy: the SMART-MR study.
Kloppenborg RP; Nederkoorn PJ; Grool AM; Vincken KL; Mali WP; Vermeulen M; van der Graaf Y; Geerlings MI;
Neurology; 2012 Nov; 79(20):2029-36. PubMed ID: 23115210
[TBL] [Abstract][Full Text] [Related]
56. C terminus of Hsc70-interacting protein (CHIP)-mediated degradation of hippocampal estrogen receptor-alpha and the critical period hypothesis of estrogen neuroprotection.
Zhang QG; Han D; Wang RM; Dong Y; Yang F; Vadlamudi RK; Brann DW
Proc Natl Acad Sci U S A; 2011 Aug; 108(35):E617-24. PubMed ID: 21808025
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
